The above results indicate that ZSCAN20 can be deemed to be an independent prognostic factor for the survival of HCC sufferers, and high expression of ZSCAN20 corresponds with the poor prognosis of HCC patients. This evidence concerns the gene ZSCAN20 and hepatocellular carcinoma.